作者
Jean-Frederic Colombel, Edward V Loftus, Corey A Siegel, James Lewis, Michael D Smyth, Serap Sankoh, Brihad Abhyankar
发表日期
2015/4/1
期刊
Gastroenterology
卷号
148
期号
4
页码范围
S-277-S-278
出版商
WB Saunders
简介
Sa1268 Individualized Therapy Is Long-Term Cost-Effective Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab Casper Steenholdt, Jorn Brynskov, Ole Thomsen, Lars K. Munck, Jan Fallingborg, Lisbet A. Christensen, Gitte Pedersen, Jens Kjeldsen, Bent A. Jacobsen, Anne Sophie Oxholm, Jakob Kjellberg, Klaus Bendtzen, Mark A. Ainsworth Background: Infliximab (IFX) treatment failure in patients with Crohn's disease is generally handled by intensifying the IFX regimen. However, an alternative strategy defined by an algorithm based on serum IFX and anti-IFX antibody measurements to identify reasons for failure and corresponding interventions has been proposed. In a randomized controlled trial, we observed substantial cost reductions after 12 weeks when using this algorithm as compared to IFX intensification, and without negative influence on symptom control.(1) The current study …
学术搜索中的文章
JF Colombel, EV Loftus, CA Siegel, J Lewis, MD Smyth… - Gastroenterology, 2015